|
Fusion gene ID: 32302 |
FusionGeneSummary for RSPO3_TXNL1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: RSPO3_TXNL1 | Fusion gene ID: 32302 | Hgene | Tgene | Gene symbol | RSPO3 | TXNL1 | Gene ID | 84870 | 9352 |
Gene name | R-spondin 3 | thioredoxin like 1 | |
Synonyms | CRISTIN1|PWTSR|THSD2 | HEL-S-114|TRP32|TXL-1|TXNL|Txl | |
Cytomap | 6q22.33 | 18q21.31 | |
Type of gene | protein-coding | protein-coding | |
Description | R-spondin-3R-spondin 3 homologprotein with TSP type-1 repeatroof plate-specific spondin-3thrombospondin type-1 domain-containing protein 2thrombospondin, type I, domain containing 2 | thioredoxin-like protein 132 kDa thioredoxin-related proteinepididymis secretory protein Li 114thioredoxin-related 32 kDa proteinthioredoxin-related protein 1 | |
Modification date | 20180523 | 20180522 | |
UniProtAcc | Q9BXY4 | O43396 | |
Ensembl transtripts involved in fusion gene | ENST00000356698, ENST00000368317, ENST00000485757, | ENST00000217515, ENST00000585497, ENST00000590954, ENST00000540155, | |
Fusion gene scores | * DoF score | 3 X 3 X 1=9 | 3 X 3 X 1=9 |
# samples | 3 | 3 | |
** MAII score | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: RSPO3 [Title/Abstract] AND TXNL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BE706582 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000356698 | ENST00000217515 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000356698 | ENST00000585497 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000356698 | ENST00000590954 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000356698 | ENST00000540155 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000368317 | ENST00000217515 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000368317 | ENST00000585497 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000368317 | ENST00000590954 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000368317 | ENST00000540155 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000485757 | ENST00000217515 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000485757 | ENST00000585497 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000485757 | ENST00000590954 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
intron-intron | ENST00000485757 | ENST00000540155 | RSPO3 | chr6 | 127079239 | - | TXNL1 | chr18 | 54300194 | - |
Top |
FusionProtFeatures for RSPO3_TXNL1 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
RSPO3 | TXNL1 |
Activator of the canonical Wnt signaling pathway byacting as a ligand for LGR4-6 receptors, which acts as a keyregulator of angiogenesis. Upon binding to LGR4-6 (LGR4, LGR5 orLGR6), LGR4-6 associate with phosphorylated LRP6 and frizzledreceptors that are activated by extracellular Wnt receptors,triggering the canonical Wnt signaling pathway to increaseexpression of target genes. Also regulates the canonical Wnt/beta-catenin-dependent pathway and non-canonical Wnt signaling byacting as an inhibitor of ZNRF3, an important regulator of the Wntsignaling pathway. Acts as a ligand for frizzled FZD8 and LRP6.May negatively regulate the TGF-beta pathway (PubMed:21727895,PubMed:21909076, PubMed:22615920). Acts as a key regulator ofangiogenesis by controlling vascular stability and pruning: actsby activating the non-canonical Wnt signaling pathway inendothelial cells (By similarity). {ECO:0000250|UniProtKB:Q2TJ95,ECO:0000269|PubMed:21727895, ECO:0000269|PubMed:21909076,ECO:0000269|PubMed:22615920}. | Active thioredoxin with a redox potential of about -250mV. {ECO:0000269|PubMed:19349277}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for RSPO3_TXNL1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for RSPO3_TXNL1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for RSPO3_TXNL1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for RSPO3_TXNL1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | RSPO3 | C1458155 | Mammary Neoplasms | 1 | CTD_human |